Does offering an incentive payment improve recruitment to clinical trials and increase the proportion of socially deprived and elderly participants?

Trials

Volumn 16, Issue 1, 2015, Pages

  Jennings, Claudine G ^a   MacDonald, Thomas M ^a   Wei, Li ^b   Brown, Morris J ^c   McConnachie, Lewis ^a   Mackenzie, Isla S ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Clinical trial recruitment; Incentive payment; Patient demographics

Indexed keywords

ALLOPURINOL; CELECOXIB; DIURETIC AGENT; FEBUXOSTAT;

ADULT; AGE; AGED; ARTICLE; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; COST; COST EFFECTIVENESS ANALYSIS; DIURETIC THERAPY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; INCENTIVE PAYMENT; INFORMED CONSENT; LETTER; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MIDDLE AGED; MONOTHERAPY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT IDENTIFICATION; PATIENT INFORMATION; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SCREENING; SOCIAL ISOLATION; UNITED KINGDOM; YOUNG ADULT; COST BENEFIT ANALYSIS; ECONOMICS; RANDOMIZATION; STATISTICAL MODEL;

AGED; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT SELECTION; RANDOM ALLOCATION;

EID: 84928819105     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-0582-8     Document Type: Article

References (17)

1. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283:2701-11.
2. Rochon PA, Berger PB, Gordon M. The evolution of clinical trials: inclusion and representation. CMAJ. 1998;159:1373-4.
3. Treweek S, Lockhart P, Pitkethly M, Cook JA, Kjeldstrøm M, Johansen M, et al. Methods to improve recruitment to randomised controlled trials: cochrane systematic review and meta-analysis. BMJ Open. 2013;3:002360.
4. Mackenzie IS, Wei L, Rutherford D, Findlay EA, Saywood W, Campbell MK, et al. Promoting public awareness of randomised clinical trials using the media: the 'Get Randomised' campaign. Br J Clin Pharmacol. 2010;69:128-35.
5. Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R, et al. Recruitment to randomised trials: strategies for trial enrolment and participation study: the STEPS study. Health Technol Assess. 2007;11(48).
6. Tishler CL, Bartholomae S. The recruitment of normal healthy volunteers: a review of the literature on the use of financial incentives. J Clin Pharmacol. 2002;42:365-75.
7. Dickert N, Emanuel E, Grady C. Paying research subjects: an analysis of current policies. Ann Intern Med. 2002;136:368-73.
8. Halpern SD, Karlawish JHT, Casarett D, Berlin JA, Asch DA. Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Arch Intern Med. 2004;164:801-3.
9. MacDonald TM, Mackenzie IS, Wei L, Hawkey CJ, Ford I, SCOT study group collaborators. Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT). BMJ Open. 2013;3:002295.
10. Martinson BC, Lazovich D, Lando HA, Perry CL, McGovern PG, Boyle RG. Effectiveness of monetary incentives for recruiting adolescents to an intervention trial to reduce smoking. Prev Med. 2000;31:706-13.
11. Scottish Index of Multiple Deprivation (SIMD). Office of the Chief Statistician and Performance, Scottish Government, Edinburgh. http://www.gov.scot/Topics/Statistics/SIMD Accessed 13 Feb 2015.
12. Titmuss RM. The gift relationship: from human blood to social policy. London: George Allen & Unwin; 1970.
13. Frey BS, Oberholzer-Gee F. The cost of price incentives: an empirical analysis of motivation crowding-out. Am Econ Rev. 1997;87:746-55.
14. Draper H, Wilson S, Flanagan S, Ives J. Offering payments, reimbursement and incentives to patients and family doctors to encourage participation in research. Fam Pract. 2009;26:231-8.
15. Jones E, Liddell K. Should healthy volunteers in clinical trials be paid according to risk? Yes. BMJ. 2009;339:b4142.
16. Saunders J. Should healthy volunteers in clinical trials be paid according to risk? No. BMJ. 2009;339:b4145.
17. Wong JC, Bernstein M. Payment of research subjects for more than minimal risk trials is unethical. Am J Med Sci. 2011;342:294-6.